5P01NS030318-18 |
2010 |
$169643 |
9002 |
Clinical |
5P01NS030318-18 |
2010 |
$153150 |
9003 |
Animal Modeling and Outcome |
5P01NS030318-18 |
2010 |
$152693 |
10 |
INOS and TBI |
5P01NS030318-18 |
2010 |
$147260 |
15 |
Fas-Mediated Cell Death in TBI |
5P01NS030318-18 |
2010 |
$1184864 |
None |
Emerging Therapeutics for Traumatic Brain Injury (TBI) - Acute to Chronic Changes |
5P01NS030318-18 |
2010 |
$120340 |
9001 |
Administration and Biostatistics |
5P01NS030318-18 |
2010 |
$147258 |
14 |
Calcineurin Inhibition as a Therapeutic Target for TBI |
5P01NS030318-18 |
2010 |
$147263 |
13 |
Poly(ADP-Ribose) Polymerase and Brain Injury |
5P01NS030318-18 |
2010 |
$147257 |
9 |
TBI; AMYLOID METABOLISM AND STATIN THERAPY |
5P01NS030318-17 |
2009 |
$148751 |
15 |
Fas-Mediated Cell Death in TBI |
3P01NS030318-17S1 |
2009 |
$173922 |
None |
Emerging Therapeutics for Traumatic Brain Injury (TBI) - Acute to Chronic Changes |
5P01NS030318-17 |
2009 |
$172545 |
9002 |
Clinical |
5P01NS030318-17 |
2009 |
$154697 |
9003 |
Animal Modeling and Outcome |
5P01NS030318-17 |
2009 |
$148746 |
10 |
INOS and TBI |
5P01NS030318-17 |
2009 |
$1191342 |
None |
Emerging Therapeutics for Traumatic Brain Injury (TBI) - Acute to Chronic Changes |
5P01NS030318-17 |
2009 |
$120365 |
9001 |
Administration and Biostatistics |
5P01NS030318-17 |
2009 |
$148747 |
14 |
Calcineurin Inhibition as a Therapeutic Target for TBI |
5P01NS030318-17 |
2009 |
$148746 |
13 |
Poly(ADP-Ribose) Polymerase and Brain Injury |
5P01NS030318-17 |
2009 |
$148745 |
9 |
TBI; AMYLOID METABOLISM AND STATIN THERAPY |
5P01NS030318-16 |
2008 |
$148747 |
9 |
TBI; AMYLOID METABOLISM AND STATIN THERAPY |
5P01NS030318-16 |
2008 |
$172550 |
9002 |
Clinical |
5P01NS030318-16 |
2008 |
$154697 |
9003 |
Animal Modeling and Outcome |
5P01NS030318-16 |
2008 |
$148749 |
10 |
INOS and TBI |
5P01NS030318-16 |
2008 |
$148750 |
15 |
Fas-Mediated Cell Death in TBI |
5P01NS030318-16 |
2008 |
$1191353 |
None |
Emerging Therapeutics for Traumatic Brain Injury (TBI) - Acute to Chronic Changes |
5P01NS030318-16 |
2008 |
$120365 |
9001 |
Administration and Biostatistics |
5P01NS030318-16 |
2008 |
$148746 |
14 |
Calcineurin Inhibition as a Therapeutic Target for TBI |
5P01NS030318-16 |
2008 |
$148749 |
13 |
Poly(ADP-Ribose) Polymerase and Brain Injury |